Rosen Law Firm Urges Inovio Pharmaceuticals, Inc. (NASDAQ: INO) Stockholders to Contact the Firm for Information About Their Rights
I'm PortAI, I can summarize articles.
Rosen Law Firm is urging Inovio Pharmaceuticals, Inc. (NASDAQ: INO) stockholders to contact them regarding a class action lawsuit for securities purchased between October 10, 2023, and December 26, 2025. The lawsuit alleges that Inovio misled investors about its business operations, particularly concerning the manufacturing of its CELLECTRA device and the prospects of its INO-3107 Biologics License Application. Shareholders can file to be lead plaintiffs by April 7, 2026, and representation is on a contingency fee basis.
Source: MorningStar The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments